Format

Send to

Choose Destination
Dev Cell. 2015 Jul 27;34(2):181-91. doi: 10.1016/j.devcel.2015.05.009. Epub 2015 Jul 2.

A long non-coding RNA, LncMyoD, regulates skeletal muscle differentiation by blocking IMP2-mediated mRNA translation.

Author information

1
Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
2
Novartis Institutes for Biomedical Research, Basel 4002, Switzerland.
3
Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. Electronic address: david.glass@novartis.com.

Abstract

Increasing evidence suggests that long non-coding RNAs (LncRNAs) represent a new class of regulators of stem cells. However, the roles of LncRNAs in stem cell maintenance and myogenesis remain largely unexamined. For this study, hundreds of intergenic LncRNAs were identified that are expressed in myoblasts and regulated during differentiation. One of these LncRNAs, termed LncMyoD, is encoded next to the Myod gene and is directly activated by MyoD during myoblast differentiation. Knockdown of LncMyoD strongly inhibits terminal muscle differentiation, largely due to a failure to exit the cell cycle. LncMyoD directly binds to IGF2-mRNA-binding protein 2 (IMP2) and negatively regulates IMP2-mediated translation of proliferation genes such as N-Ras and c-Myc. While the RNA sequence of LncMyoD is not well conserved between human and mouse, its locus, gene structure, and function are preserved. The MyoD-LncMyoD-IMP2 pathway elucidates a mechanism as to how MyoD blocks proliferation to create a permissive state for differentiation.

PMID:
26143994
DOI:
10.1016/j.devcel.2015.05.009
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center